Skip to content

Life sciences

Filters

Showing results for


Clear all
Let the use case decide: The Zelta way on AI and supervised machine learning

For decades, when people thought of artificial intelligence (AI) what usually...

By Walker Bradham | 2 min. read

Five questions to ask before choosing a real-world data provider

When you’re working with real-world data (RWD) in a clinical trial setting, you must...

By Liisa Palmer | 6 min. read

Zelta user success stories: Faster timelines, cleaner data, in-house flexibility

This month we’re profiling just a few of the CROs, sponsors, biotech, and pharma...

By Kofi Darkoh | 4 min. read

Mortality data: Driving health research forward

Learn how the MarketScan Mortality Database can help generate insights, examine...

By Mette Andersen | 2 min. read

The missing puzzle piece: Linking MarketScan claims data with Veradigm EHR data

This new healthcare database unlocks the whole picture of patient care at an...

By Mette Andersen | 2 min. read

Zelta ranked as a Leader in Everest Group’s 2024 EDC Products PEAK® Matrix Assessment

We’re excited to announce that Zelta has been officially ranked as a Leader in the...

By Jennifer Duff | 4 min. read

Gene therapy: How Veristat cut trial database costs by 30%

This piece originally appeared in Pharmaceutical Technology. The gene therapy...

By Jennifer Duff | 7 min. read

Optimize sample size and observation time: A case for employer-sourced administrative claims data

Closed administrative claims databases capture the complete range of healthcare...

By Merative | 5 min. read

Untapped opportunities: Fulfilling the promise of decentralized clinical trials

This piece originally appeared in Pharmaceutical Technology. The uptake of...

By Wes Fishburne | 6 min. read

4 ways the vaccine rush is defining infectious disease trends for CROs in 2024

This piece originally appeared on Pharmaceutical Technology. The global healthcare...

By Jennifer Duff | 5 min. read

Three real-world data research and regulatory trends to watch in 2024 and beyond

The Professional Society for Health Economics and Outcomes Research, known as...

By Merative | 5 min. read

The future of Zelta on display at the 2024 User Conference

That’s a wrap on the 2nd annual Zelta User Conference! We had a wonderful,...

By Jennifer Duff | 5 min. read

Oncology in 2024: The clinical trial trends reshaping the role of CROs

This piece originally appeared on Pharmaceutical Technology. Oncology is the most...

By Jennifer Duff | 7 min. read

Measure the impacts of patient productivity loss and caregiver burden with real-world data

When patients are struck with illness, their quality of life and well-being are of...

By Eleanor Gebauer | 5 min. read

Four ways a holistic ecosystem for clinical trials can help boost ROI

This piece originally appeared on Clinical Leader Clinical trials are complex and...

By Jennifer Duff | 9 min. read

Advance rare diseases research with closed claims real-world data

MarketScan real-world data has been used to assess illness burden of rare diseases,...

By Eleanor Gebauer | 8 min. read

Zelta surpasses 4,000 clinical trial studies

February 2024 marked a major milestone for Zelta: the platform has now hosted over...

By Jennifer Duff | 3 min. read

What’s more important: Real-world data quality or speed?

Here is what executives from biopharma and medical device companies had to say...

By Eleanor Gebauer | 2 min. read

Can Your Clinical Trial Design Handle Mid-Study Changes?

As clinical research advances, the pharmaceutical and biotech industries...

By Walker Bradham | 7 min. read

Zelta expands its clinical trial ecosystem with a new partnership

At Zelta, we understand that collaboration is the name of the game when it comes to...

By Merative | 2 min. read

Lifesaving oncology research deserves cutting-edge solutions

The race to develop novel, advanced therapeutics for cancer patients is fast and...

By Jennifer Duff | 7 min. read

New report confirms Zelta by Merative is a Major Contender

Merative has been named a Major Contender in Everest Group’s Life Sciences Clinical...

By Shannon Reilly | 5 min. read

Looking beyond the bump with real-world evidence

Recent moves by the U.S. Federal Drug Administration (FDA) to open clinical studies...

By Eleanor Gebauer | 4 min. read

Three years after COVID-19, the conversation around DCTs is shifting again

While interest in decentralized clinical trials (DCTs) has been heating up lately,...

By Wes Fishburne | 6 min. read

The disconnect between clinical trial technology and legacy habits

In today’s age of cloud computing and data integration solutions, there are simple...

By Jennifer Duff | 4 min. read

Merative Clinical Development has a new name

General Manager Jennifer Duff describes what the new name means for Merative’s...

By Jennifer Duff | 2 min. read

Questions to ask when managing drug shortages

Drug shortages are nothing new, but the COVID-19 pandemic exacerbated this...

By Merative | 1 min. read

Connecting with the clinical development community

The time it takes to design, launch and complete clinical trials is a problem many...

By Jennifer Duff | 2 min. read

Will DCTs finally democratize clinical trials?

Zelta Product Leader Walker Bradham and Senior Product Manager Wes Fishburne...

By Walker Bradham | 4 min. read

Cardiovascular image and data management: A technical and clinical evolution

By Merative | 4 min. read

Is real-world data the real deal?

Real-world data is Liisa’s world. After receiving her PhD in health policy and...

By Liisa Palmer | 4 min. read

Beyond KLAS rankings: building client relationships at Merative

By David Gruen | 3 min. read